ABHD5

abhydrolase domain containing 5, lysophosphatidic acid acyltransferase, the group of Abhydrolase domain containing

Basic information

Region (hg38): 3:43690108-43734371

Links

ENSG00000011198NCBI:51099OMIM:604780HGNC:21396Uniprot:Q8WTS1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Dorfman-Chanarin disease (Definitive), mode of inheritance: AR
  • Dorfman-Chanarin disease (Strong), mode of inheritance: AR
  • Dorfman-Chanarin disease (Strong), mode of inheritance: AR
  • Dorfman-Chanarin disease (Supportive), mode of inheritance: AR
  • Dorfman-Chanarin disease (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Chanarin-Dorfman syndromeARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Dermatologic10712205; 11590543; 21757733; 22245374; 22373837; 25468645
Manifestations can include severe hepatic sequelae

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ABHD5 gene.

  • not_provided (182 variants)
  • Triglyceride_storage_disease_with_ichthyosis (48 variants)
  • Inborn_genetic_diseases (37 variants)
  • ABHD5-related_disorder (8 variants)
  • not_specified (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABHD5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016006.6. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
57
clinvar
2
clinvar
62
missense
3
clinvar
2
clinvar
89
clinvar
6
clinvar
1
clinvar
101
nonsense
8
clinvar
3
clinvar
11
start loss
0
frameshift
6
clinvar
2
clinvar
8
splice donor/acceptor (+/-2bp)
3
clinvar
2
clinvar
5
Total 20 9 92 63 3

Highest pathogenic variant AF is 0.0000123908

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ABHD5protein_codingprotein_codingENST00000458276 744259
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.42e-70.8931257180301257480.000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4741661840.9020.000009332261
Missense in Polyphen3247.9160.66784614
Synonymous-1.988665.61.310.00000343679
Loss of Function1.631321.10.6180.00000150218

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002420.000242
Ashkenazi Jewish0.000.00
East Asian0.0002720.000272
Finnish0.000.00
European (Non-Finnish)0.00008800.0000879
Middle Eastern0.0002720.000272
South Asian0.0003270.000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Lysophosphatidic acid acyltransferase which functions in phosphatidic acid biosynthesis (PubMed:18606822). May regulate the cellular storage of triacylglycerol through activation of the phospholipase PNPLA2 (PubMed:16679289). Involved in keratinocyte differentiation (PubMed:18832586). Regulates lipid droplet fusion (By similarity). {ECO:0000250|UniProtKB:Q9DBL9, ECO:0000269|PubMed:16679289, ECO:0000269|PubMed:18606822, ECO:0000269|PubMed:18832586}.;
Disease
DISEASE: Chanarin-Dorfman syndrome (CDS) [MIM:275630]: An autosomal recessive inborn error of lipid metabolism with multisystemic accumulation of triglycerides although plasma concentrations are normal. Clinical characteristics are congenital generalized ichthyosis, vacuolated leukocytes, hepatomegaly, myopathy, cataracts, neurosensory hearing loss and developmental delay. The disorder presents at birth with generalized, fine, white scaling of the skin and a variable degree of erythema resembling non-bullous congenital ichthyosiform erythroderma. {ECO:0000269|PubMed:11590543, ECO:0000269|PubMed:16679289, ECO:0000269|PubMed:17495960, ECO:0000269|PubMed:18606822}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Regulation of lipolysis in adipocytes - Homo sapiens (human);Lipid Metabolism Pathway;Liver steatosis AOP;Metabolism of lipids;Metabolism;CDP-diacylglycerol biosynthesis;Triglyceride catabolism;Triglyceride metabolism;triacylglycerol biosynthesis (Consensus)

Recessive Scores

pRec
0.163

Intolerance Scores

loftool
0.469
rvis_EVS
-0.42
rvis_percentile_EVS
25.56

Haploinsufficiency Scores

pHI
0.100
hipred
N
hipred_score
0.333
ghis
0.552

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.283

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Abhd5
Phenotype
immune system phenotype; skeleton phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;

Gene ontology

Biological process
fatty acid metabolic process;phosphatidic acid biosynthetic process;negative regulation of sequestering of triglyceride;positive regulation of triglyceride catabolic process;cell differentiation;positive regulation of lipoprotein lipase activity;lipid homeostasis
Cellular component
lipid droplet;cytosol
Molecular function
1-acylglycerol-3-phosphate O-acyltransferase activity;triglyceride lipase activity;lysophosphatidic acid acyltransferase activity;carboxylic ester hydrolase activity